Special Stocks Analysis: ImmunoCellular Therapeutics, Vodafone Group, BlackBerry Ltd, Galena Biopharma Incadmin
New York, December 24, 2013 / Accesswire / – Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for Vodafone Group Plc (ADR) (NASDAQ:VOD), BlackBerry Ltd (NASDAQ:BBRY), Galena Biopharma Inc (NASDAQ:GALE), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC).
Vodafone Group Plc (ADR)(NASDAQ:VOD) shares gained 0.21% to $38.63. The company on Dec. 20 agreed on a so-called domination agreement with Kabel Deutschland , three months after its 7.7 billion euro ($10.5 billion) acquisition of Germany’s largest cable company went through. Vodafone will offer the remaining shareholders of Kabel Deutschland 84.53 euros for each of their shares, slightly more than the 84.50 euros it had offered in its takeover bid June.
Free Urgent Insider Catalyst Report For VOD Available Here: http://marketbuzzreport.com/index.php?code=VOD (Or Copy and paste the URL into your browser)
BlackBerry Ltd (NASDAQ:BBRY) shares jumped 1.58% to $7.59. The company on Dec. 20 reported a massive $4.4 billion loss in the third quarter and 56 percent drop in revenue. The company reported revenue of $1.2 billion, down 56 per cent in the same quarter last year. Its adjusted loss from continuing operations was $354 million, or 67 cents per share. Analysts polled by FactSet, on average, expect a loss of 43 cents per share on revenue of $1.66 billion.
Additionally, the company on Dec. 20 announced that it has entered into a five-year strategic partnership with Foxconn, the world’s largest manufacturer of electronic products and components. The initial focus of the partnership will be a smartphone for Indonesia and other fast-growing markets targeting early 2014.
Free Urgent Insider Catalyst Report For BBRY Available Here: http://marketbuzzreport.com/index.php?code=BBRY (Or Copy and paste the URL into your browser)
Galena Biopharma Inc (NASDAQ:GALE) shares jumped 0.50% to $4.06. The company announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, presented a corporate update at the Oppenheimer 24th Annual Healthcare Conference. The presentation took place on Tuesday, December 10, 2013 at 10:55 a.m. ET at the Crowne Plaza Hotel in New York, NY.
Additionally, Research firm Oppenheimer initiated coverage on the stocks of GALE to an Outperform rating on Nov. 26.
Free Urgent Insider Catalyst Report For GALE Available Here: http://marketbuzzreport.com/index.php?code=GALE (Or Copy and paste the URL into your browser)
Shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) are trading sharply higher in premarket action. Investors appear to be reacting to a press release out after the bell Monday in which the company said the first patient in a Phase 1 study of ICT-121 (another dendritic cell cancer vaccine) has received the treatment. Notably, the company provides a bit of commentary on ICT-107 which, investors will recall, was behind a dramatic decline in IMUC’s shares earlier this month when the OS K-M curves failed to hit statistical significance in a Phase 2 study.
IMUC says it “urges patients and other stakeholders to look beyond the unsubstantiated commentary on the recent trial results to what [the company] and clinical experts believe are important findings from this clinical program to date.” Further, IMUC says “nationally renowned neuro-oncologists … share [the company’s] view that as the survival data mature in 2014, there is the potential to see clarification of the survival benefit of the ICT-107 treated group.”
Free Urgent Insider Catalyst Report For IMUC Available Here: http://marketbuzzreport.com/index.php?code=IMUC (Or Copy and paste the URL into your browser)
USMarketBuzz.com is an investment community that Focuses on MicroCap Securities. USMarketBuzz.com is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/ for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.USMarketBuzz.com/. Follow us on Facebook: https://www.facebook.com/usmarket.buzz Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126 (SMS alerts are free, however data rates may apply, check your wireless plan for details.).
Posted: December 24th, 2013 under ACCESSWIRE.